Chardan Capital Starts Signal Genetics (SGNL) at Buy; MyPRS Test Could See Big Demand
Tweet Send to a Friend
Chardan Capital Markets initiates coverage on Signal Genetics (NASDAQ: SGNL) with a Buy rating and a price target of $2.50.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
